Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 55%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is poised for success with their unique integrated platform that supports individuals with multiple chronic conditions and a strong focus on retention and expansion through partnerships. They have a track record of delivering measurable health outcomes and have gained attention with their specialized care for GLP-1 medications. Financially, the company has high margins and is expected to continue surpassing expectations as their customer base grows.

Bears say

Omada Health is a next-generation virtual care provider with a comprehensive platform and growing demand for metabolic health management solutions, but its negative outlook is due to concerns about its declining Average Revenue Per User (ARPU) and competition from peers, particularly Hinge Health, DarioHealth, and Vida Health, who have shown strong revenue growth and have partnerships with major health plans and employers. Additionally, while Omada is well-positioned in the dynamic and growing cardiometabolic market, its relatively low multiple valuation compared to its peers is a cause for concern.

OMDA has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 55% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 11 analysts, OMDA has a Buy consensus rating as of May 12, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $22.73, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $22.73, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.